Clinical significance of immunoglobulin A versus immunoglobulins G and M anti-cardiolipin antibodies in patients with systemic lupus erythematosus. Correlation with thrombosis, thrombocytopenia, and recurrent abortion.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  American Journal of Clinical Pathology

• Publication date

  1992-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/AJCP/98.4.449PMID 1415024
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Special report. The Second International Anti-cardiolipin Standardization Workshop/the Kingston Anti-Phospholipid Antibody Study (KAPS) group.

  1990cited by this paper
• Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance.

  1990cited by this paper
• Prevalence of lupus anticoagulant and anticardiolipin antibodies in a healthy population.

  1990cited by this paper
• A reassessment of the antiphospholipid syndrome.

  1990cited by this paper
• Pulmonary thromboembolism associated with procainamide induced lupus syndrome and anticardiolipin antibodies.

  1989cited by this paper
• Chlorpromazine‐induced anticardiolipin antibodies and lupus anticoagulant: Absence of thrombosis

  1988cited by this paper
• Studies of IgG, IgM and IgA antiphospholipid antibody isotypes in systemic lupus erythematosus.

  1988cited by this paper
• Clinical significance of a single test for anti-cardiolipin antibodies in patients with systemic lupus erythematosus.

  1988cited by this paper
• Anticardiolipin antibodies: isotype distribution and phospholipid specificity.

  1987cited by this paper
• High prevalence of anti-cardiolipin and other autoantibodies in a healthy elderly population.

  1987cited by this paper
• Anti-cardiolipin antibodies in neurological disorders: cross-reaction with anti-single stranded DNA activity.

  1987cited by this paper
• Thrombosis, recurrent fetal loss, and thrombocytopenia. Predictive value of the anticardiolipin antibody test.

  1986cited by this paper
• The anticardiolipin syndrome.

  1985cited by this paper
• Thromboembolism in patients with the 'lupus'-type circulating anticoagulant.

  1984cited by this paper
• Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus.

  1983cited by this paper
• The 1982 revised criteria for the classification of systemic lupus erythematosus.

  1982cited by this paper
• Thrombosis in patients with the lupus anticoagulant.

  1980cited by this paper
• THROMBOSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS DESPITE CIRCULATING ANTICOAGULANTS.

  1963cited by this paper

• Antiphospholipid Syndrome—Diagnostic and Methodologic Approach

  2025cites this paper
• A Retrospective Study on Antinuclear Antibody Patterns in Systemic Lupus Erythematosus Patients and Its Correlation With Serological Markers

  2023cites this paper
• Anti-Nuclear Antibodies Patterns in Patients With Systemic Lupus Erythematosus and Their Correlation With Other Diagnostic Immunological Parameters

  2022cites this paper
• Antiphospholipid antibodies quantification using ALBIA technology: how to define an optimal cutoff?

  2021cites this paper
• Elevated IgA antiphospholipid antibodies in healthy pregnant women in Sudan but not Sweden, without corresponding increase in IgA anti-β2 glycoprotein I domain 1 antibodies

  2020cites this paper
• The Weight of IgA Anti-β2glycoprotein I in the Antiphospholipid Syndrome Pathogenesis: Closing the Gap of Seronegative Antiphospholipid Syndrome

  2020cites this paper
• Skin and Lacrimal Drainage System

  2020cites this paper
• Is There an Additional Value in Detecting Anticardiolipin and Anti-β2 glycoprotein I IgA Antibodies in the Antiphospholipid Syndrome?

  2020cites this paper
• Laboratory Markers With Clinical Significance in the Antiphospholipid Syndrome

  2017cites this paper
• Differential assay reactivity of immunglobulin A anti-ß2 glycoprotein I antibodies: implications for the clinical interpretation of antiphospholipid antibody testing.

  2015cites this paper
• The emerging role of multiple antiphospholipid antibodies positivity in patients with antiphospholipid syndrome

  2015cites this paper
• Phospholipid-independent Binding of j 52 glycoprotein I by IgA from Patients with Antipnospholipia Syndrome

  2015cites this paper
• 14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends.

  2014cites this paper
• Utility of Antiphosphatidylserine/Prothrombin and IgA Antiphospholipid Assays in Systemic Lupus Erythematosus

  2013cites this paper
• Clinical Significance of IgA Anti-Cardiolipin and IgA Anti-β2Glycoprotein I Antibodies

  2013cites this paper
• Task Force Report on “Non-criteria” Antiphospholipid Antibody Tests

  2012cites this paper
• International consensus guidelines on anticardiolipin and anti-β2-glycoprotein I testing: report from the 13th International Congress on Antiphospholipid Antibodies.

  2012cites this paper
• ‘Non-criteria’ aPL tests: report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, TX, USA, April 2010

  2011cites this paper
• ' Non-criteria ' aPL tests : report of a task force and preconference workshop at the 13 th International

  2011cites this paper
• Clinical and Laboratory Evaluation of Systemic Rheumatic Diseases

  2011cites this paper
• Antiphospholipid Syndrome in the Older Population

  2011cites this paper
• ‘Criteria’ aPL tests: Report of a Task Force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, Texas, April 2010

  2011cites this paper
• Acquired and inherited thrombophilia disorders in pregnancy.

  2011cites this paper
• Chapter 3 Laboratory Heterogeneity of Antiphospholipid Antibodies

  2009cites this paper
• A Quarter of a Century in Anticardiolipin Antibody Testing and Attempted Standardization Has Led Us to Here, which Is?

  2008cites this paper
• Novel Insights Into Associations of Antibodies Against Cardiolipin and beta2-glycoprotein I with Clinical Features of Antiphospholipid Syndrome

  2007cites this paper
• Hemocytopenias in Antiphospholipid Syndrome

  2006cites this paper
• Clinical significance of IgA anticardiolipin and anti-β2-GP1 antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome

  2006cites this paper
• Prevalence and clinical correlates of anti‐phospholipid antibodies in South Africans with systemic lupus erythematosus

  2006cites this paper
• Laboratory diagnosis and management challenges in the antiphospholipid syndrome

  2006cites this paper
• Clinical laboratory testing for the antiphospholipid syndrome.

  2005cites this paper
• Ethnic and geographical variation in antiphospholipid (Hughes) syndrome

  2005cites this paper
• Nodular regenerative hyperplasia of the liver and coeliac disease: potential role of IgA anticardiolipin antibody

  2004cites this paper
• Oxidized low-density lipoprotein/beta2-glycoprotein I complexes and autoantibodies to oxLig-1/beta2-glycoprotein I in patients with systemic lupus erythematosus and antiphospholipid syndrome.

  2004cites this paper
• Anti-beta 2-glycoprotein I and antiphosphatidylserine antibodies are predictors of arterial thrombosis in patients with antiphospholipid syndrome.

  2004cites this paper
• Oxidized Low-Density Lipoprotein/β2-Glycoprotein I Complexes and Autoantibodies to oxLig-1/β2-Glycoprotein I in Patients with Systemic Lupus Erythematosus and Antiphospholipid Syndrome

  2004cites this paper
• Antiphospholipid antibodies: discovery, definitions, detection and disease.

  2003cites this paper
• Revisiting the anticardiolipin test and its standardization

  2002cites this paper
• Antibodies to Cardiolipin and other Phospholipids

  2002cites this paper
• Autoimmune Causes of Recurrent Pregnancy Loss

  2002cites this paper
• Immunoglobulin A anti-beta2-glycoprotein antibodies in women who experience unexplained recurrent spontaneous abortion and unexplained fetal death.

  2001cites this paper
• Prevalence and isotype distribution of antiphospholipid antibodies in Chilean patients with systemic lupus erythematosus (SLE)

  2001cites this paper
• The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.

  2001cites this paper
• The clinical significance of IgA antiphospholipid antibodies.

  2001influential citation
• Antiphospholipid Syndrome: General Features

  2000cites this paper
• Antiphospholipid (Hughes') syndrome in African-Americans: IgA aCL and aβ2 glycoprotein-I is the most frequent isotype

  1999cites this paper
• High Levels of IgA Anticardiolipin Antibodies in Patients with Systemic Lupus erythematosus, Henoch-Schoenlein Purpura, Sneddon’s Syndrome and Recurrent Pregnancy Loss

  1999cites this paper
• IgA anticardiolipin and anti-beta2-glycoprotein I are the most prevalent isotypes in African American patients with systemic lupus erythematosus.

  1999cites this paper
• Diagnostic approach of phospholipid-dependent antibodies. State-of-the art lecture.

  1999cites this paper
• Distribution of lupus anticoagulant and anticardiolipin antibody isotypes in a population with antiphospholipid syndrome.

  1999cites this paper
• Isotype distribution and clinical relevance of anti-beta2-glycoprotein I (beta2-GPI) antibodies: importance of IgA isotype.

  1999cites this paper
• Evaluation of the Different Antiphospholipid Antibodies for the Diagnosis of Antiphospholipid Syndrome

  1999cites this paper
• Isotype distribution and clinical relevance of anti‐β2‐glycoprotein I (β2‐GPI) antibodies: importance of IgA isotype

  1999cites this paper
• False-positive reactions for IgA anti-phospholipid and anti-beta(2)-glycoprotein I antibodies in patients with IgA monoclonal gammopathy.

  1999cites this paper
• Qualitative and quantitative studies of autoantibodies to phospholipids in diabetes mellitus

  1999cites this paper
• Thrombophilic factors and their relation to thromboembolic and other clinical manifestations in Behçet's disease.

  1999cites this paper
• Diagnostic Approach of Phospholipid-Dependent Antibodies

  1999cites this paper
• Immunologische Vorgänge im Rahmen der Dezidualisation und beginnenden Plazentation

  1998cites this paper
• Significance of IgA antiphospholipid antibodies

  1998cites this paper
• Clinical significance of immunoglobulin A antiphospholipid antibodies: possible association with skin manifestations and small vessel vasculitis.

  1998cites this paper
• IgA Anticardiolipin Antibodies – Relation with other Antiphospholipid Antibodies and Clinical Significance

  1998cites this paper
• Phospholipid-independent binding of beta 2glycoprotein I by IgA from patients with antiphospholipid syndrome.

  1998cites this paper
• Anticorps phospholipides dépendants: données actuelles et développement de trousses de dosage optimisées

  1997cites this paper
• Variability of anticardiolipin antibody isotype distribution in 3 geographic populations of patients with systemic lupus erythematosus.

  1997cites this paper
• Antiphospholipid syndrome and the skin.

  1997cites this paper
• IgM antibodies in renal transplantation

  1997cites this paper
• Current concepts and advances in clinical laboratory testing for autoimmune diseases.

  1997cites this paper
• Antiphospholipid antibodies: standardization and testing.

  1997cites this paper
• Clinical setting of patients with systemic sclerosis by serum autoantibodies

  1997cites this paper
• Phospholipid Autoantibodies — Cardiolipin

  1996cites this paper
• Detection of IGA anti-OKT3 antibodies in OKT3-treated transplant recipients.

  1996cites this paper
• IgA class anticardiolipin antibodies in cutaneous leukocytoclastic vasculitis.

  1996cites this paper
• Myocardial infarction as the presenting manifestation of systemic lupus erythematosus with antiphosphatidylserine antibodies.

  1996cites this paper
• Clinical significance of anticardiolipin antibodies in patients with systemic sclerosis.

  1995cites this paper
• Antiphospholipid antibodies in heart transplant recipients

  1995cites this paper
• Anti-neutrophil cytoplasm antibodies in patients with ACR criteria for polyarteritis nodosa: help for systemic vasculitis classification?

  1995cites this paper
• Contemporary concepts for the clinical and laboratory evaluation of systemic lupus erythematosus and “lupus‐like” syndromes

  1994cites this paper
• Cryptic antiphospholipid autoantibodies and serum co-inhibitors.

  1994cites this paper
• Can tests for IgA, IgG, or IgM antibodies to cardiolipin or phosphatidylserine substitute for lupus anticoagulant assays in screening for antiphospholipid antibodies?

  1994cites this paper
• Antiphospholipid Antibodies: A Critique of Their Heterogeneity and Hegemony

  1994cites this paper
• Antiphospholipid Antibodies in Predicting Adverse Pregnancy Outcome: A Prospective Study

  1994cites this paper
• [Antiphospholipid syndrome: a new clinical entity? Part 1: antiphospholipid antibodies: specificity and methodological problems].

  1993cites this paper
• Anti‐cardiolipin antibodies (IgG and IgA) in women with recurrent fetal loss correlate to clinical and serological characteristics of SLE

  1993cites this paper
• Anti-phospholipid antibodies.

  1992cites this paper
• Autoimmunity and Pregnancy Loss

  1989cites this paper